ProPhase Labs, Inc. GARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and diagnostics ...

Ted Karkus, CEO of ProPhase Labs, will present to shareholders today, March 31, 2025, at 11:00 a.m. EST during the live Virtual Non-Deal Roadshow Series. The details are available below.

ProPhase Labs (PRPH), Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on Thursday, August 11, 2022 at 11:00 a.m ...

Aug. 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today reported its financial and operational ...

This quarter's event is focused on MicroCap companies who are undervalued and have a catalyst. ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer ...

ProPhase Labs announced plans to launch DNA Complete ... The company aims to reduce overhead costs by $6 million, which could result in an $11 million positive cash flow swing.

Few companies are eager for a bankruptcy filing, but ProPhase Labs might be an exception. To collect accounts receivables from its days processing Covid-19 tests done inside pop-up tents in New ...

ProPhase Labs earnings missed by $0.11, revenue fell short of estimates ...

GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and ...

Investing.com - ProPhase Labs (NASDAQ: PRPH) reported third quarter EPS of $-0.300, $0.11 worse than the analyst estimate of $-0.195. Revenue for the quarter came in at $8.37M versus the consensus ...